ResMed Inc. (RMD.AX)
AUD 36.93
(-2.51%)
AUD 36.93
(-2.51%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.4 Billion | 693.29 Million | 736.71 Million | 802.25 Million | 459.05 Million | 459.05 Million |
| Net Income | 1.02 Billion | 897.55 Million | 474.5 Million | 621.67 Million | 404.59 Million | 404.59 Million |
| Depreciation & Amortization | 216.2 Million | 197.56 Million | 191.51 Million | 181.37 Million | 150.79 Million | 150.79 Million |
| Deferred income taxes | - | 216 Thousand | -3.31 Million | 39.57 Million | 28.93 Million | 28.93 Million |
| Stock-based compensation | 80.18 Million | 71.14 Million | 65.25 Million | 63.92 Million | 57.55 Million | 52.07 Million |
| Change in working capital | 44.78 Million | -462.12 Million | 1.4 Million | -97.92 Million | -177.05 Million | -177.05 Million |
| Other non-cash items | 33.23 Million | -11.05 Million | 8.67 Million | -7000.00 | -286 Thousand | -286 Thousand |
| Investing Cash Flow | -269.78 Million | -1.15 Billion | -158.46 Million | -179.86 Million | -1.07 Billion | -1.07 Billion |
| Investments in PPE | -114.85 Million | -134 Million | -116.82 Million | -105.93 Million | -77.34 Million | -77.34 Million |
| Acquisitions | -133.46 Million | -1.01 Billion | -39.06 Million | -27.91 Million | -951.38 Million | -951.38 Million |
| Investment purchases | -22.46 Million | -32.22 Million | -21.78 Million | -46.01 Million | -46.98 Million | -46.98 Million |
| Sales/Maturities of investments | 1 Million | 19.13 Million | 19.21 Million | 19.21 Million | 8.63 Million | 998.36 Million |
| Other Investing Activities | -36.86 Million | -27.42 Million | -52.29 Million | -19.21 Million | -8.63 Million | -998.36 Million |
| Financing Cash Flow | -1.11 Billion | 422.87 Million | -764.63 Million | -764.63 Million | 580.64 Million | 580.64 Million |
| Debt repayment | -730 Million | -665 Million | -612 Million | -522 Million | -711.74 Million | -807.48 Million |
| Dividends payments | -282.32 Million | -258.27 Million | -245.34 Million | -226.71 Million | -225.09 Million | -211.71 Million |
| Common Stock Repurchased | -150.01 Million | -30.63 Million | 90 Million | -50.2 Million | -22.84 Million | -50.94 Million |
| Common Stock Issuance | 53.09 Million | 49.14 Million | 37.79 Million | 37.79 Million | 36.72 Million | 36.72 Million |
| Other Financing Activities | -10.05 Million | 46.78 Million | -53.7 Million | 34.29 Million | 1.49 Billion | 35.81 Million |
| Accounts receivables | -134.27 Million | -106.51 Million | -129.19 Million | 54.38 Million | -18.01 Million | -18.01 Million |
| Accounts payables | - | 31.34 Million | 210.7 Million | -23.42 Million | -27.27 Million | -27.27 Million |
| Inventory | 172.2 Million | -248.83 Million | -21.95 Million | -69.88 Million | -84.18 Million | -84.18 Million |
| Other working capital | -115.21 Million | -138.12 Million | -58.15 Million | -58.99 Million | -47.57 Million | -47.57 Million |
| Cash at beginning of period | 227.89 Million | 273.71 Million | 463.15 Million | 147.12 Million | 188.7 Million | 188.7 Million |
| Cash at end of period | 238.36 Million | 227.89 Million | 295.27 Million | 463.15 Million | 147.12 Million | 147.12 Million |
| Capital Expenditure | -114.85 Million | -134 Million | -116.82 Million | -105.93 Million | -77.34 Million | -77.34 Million |
| Effect of forex changes on cash | -1.71 Million | -2.14 Million | 18.49 Million | 10.92 Million | -5.56 Million | -5.56 Million |
| Net cash flow / Change in cash | 10.47 Million | -45.81 Million | -167.87 Million | 316.02 Million | -41.57 Million | -41.57 Million |
| Free Cash Flow | 1.28 Billion | 559.29 Million | 619.89 Million | 696.31 Million | 381.7 Million | 381.7 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.02 Billion | 292.23 Million | 300.49 Million | 208.8 Million | 210.47 Million | 897.55 Million |
| Depreciation & Amortization | 216.2 Million | 54.75 Million | 54.64 Million | 53.37 Million | 44.03 Million | 197.56 Million |
| Deferred income taxes | - | - | - | - | - | 216 Thousand |
| Stock-based compensation | 80.18 Million | 21.39 Million | 20.44 Million | 19.84 Million | 18.51 Million | 71.14 Million |
| Change in working capital | 44.78 Million | 57.12 Million | 40.81 Million | -43.56 Million | -232.07 Million | -462.12 Million |
| Other non-cash items | 33.23 Million | 136.57 Million | 27.88 Million | 34.38 Million | 5.3 Million | -11.05 Million |
| Investing Cash Flow | -269.78 Million | -46.5 Million | -33.15 Million | -41.14 Million | -58.8 Million | -1.15 Billion |
| Investments in PPE | -114.85 Million | -26.32 Million | -23.1 Million | -24.55 Million | -32.37 Million | -134 Million |
| Acquisitions | -133.46 Million | -19.69 Million | -3.07 Million | -7.5 Million | -19.1 Million | -1.01 Billion |
| Investment purchases | -22.46 Million | -1.23 Million | -6.96 Million | -9.08 Million | -7.33 Million | -32.22 Million |
| Sales/Maturities of investments | 1 Million | 750 Thousand | - | 1.2 Million | 250 Thousand | 19.13 Million |
| Other Investing Activities | -36.86 Million | -1.93 Million | -8.88 Million | -1.2 Million | -250 Thousand | -27.42 Million |
| Financing Cash Flow | -1.11 Billion | -393.28 Million | -335.91 Million | -238.95 Million | -41.88 Million | 422.87 Million |
| Debt repayment | -730 Million | -300 Million | -220 Million | -130 Million | -30 Million | -665 Million |
| Dividends payments | -282.32 Million | -70.55 Million | -70.49 Million | -70.67 Million | -70.59 Million | -258.27 Million |
| Common Stock Repurchased | -150.01 Million | -50 Million | -50 Million | -50 Million | 50 Million | -30.63 Million |
| Common Stock Issuance | 53.09 Million | 27.69 Million | 4.89 Million | 19.52 Million | 2.61 Million | 49.14 Million |
| Other Financing Activities | -10.05 Million | -421 Thousand | -314 Thousand | -7.79 Million | -59 Thousand | 46.78 Million |
| Accounts receivables | -134.27 Million | -57.52 Million | -56.48 Million | -26.8 Million | -56.23 Million | -106.51 Million |
| Accounts payables | - | - | - | - | 8.04 Million | 31.34 Million |
| Inventory | 172.2 Million | 8.9 Million | 86.19 Million | 50.18 Million | -147.09 Million | -248.83 Million |
| Other working capital | -115.21 Million | -16.23 Million | -24.38 Million | -66.94 Million | -36.78 Million | -138.12 Million |
| Cash at beginning of period | 227.89 Million | 237.91 Million | 210.24 Million | 209.1 Million | 273.71 Million | 273.71 Million |
| Cash at end of period | 238.36 Million | 238.36 Million | 237.91 Million | 210.24 Million | 207.16 Million | 227.89 Million |
| Capital Expenditure | -114.85 Million | -26.32 Million | -23.1 Million | -24.55 Million | -32.37 Million | -134 Million |
| Effect of forex changes on cash | -1.71 Million | 129 Thousand | -5.3 Million | 8.41 Million | -10.52 Million | -2.14 Million |
| Net cash flow / Change in cash | 10.47 Million | 451 Thousand | 27.66 Million | 1.14 Million | -66.54 Million | -45.81 Million |
| Free Cash Flow | 1.28 Billion | 413.79 Million | 378.92 Million | 248.27 Million | 12.28 Million | 559.29 Million |
CTRA
TOM
SLMNP
KNSL
AOJ-B
AOUT